The fact
This early diagnosis targets dopamine imbalances, a key marker of the disease.
A major breakthrough to treat patients before motor symptoms appear.
Click the link to read an article on the topic:
Why it matters
Ce test non invasif pourrait révolutionner la prise en charge de Parkinson en permettant une intervention plus précoce.